Matches in SemOpenAlex for { <https://semopenalex.org/work/W2547135739> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2547135739 endingPage "230" @default.
- W2547135739 startingPage "227" @default.
- W2547135739 abstract "Abstract Interferon beta is a safe and efficacious treatment for relapsing multiple sclerosis (MS). However, there is some evidence that uric acid, a scavenger of peroxynitrite, is involved in MS pathology and that increasing serum uric acid levels might have beneficial therapeutic effects. The aim of this study is to investigate serum uric acid levels in MS patients before and after long-term interferon beta treatment. Blood samples from 101 MS patients (53 receiving interferon beta 1a treatment and 48 receiving interferon beta 1b treatment; 28 male and 73 female; mean age at treatment onset 32,4±7,3 years; mean duration of disease at treatment onset 5,1±3,2 years; mean EDSS 2±1,3) before and after interferon beta treatment (mean treatment duration 3±2 years) were analysed. Serum uric acid levels were measured using a quantitative enzymatic assay (Elitech Diagnostic, Sees, France). MS patients had significantly increased serum uric acid levels after treatment compared with those at the beginning of treatment (272,31±78,21 μmol/l vs. 210,17±53,65 μmol/l; p=0,019, Wilcoxon Mann-Whitney U-test). We did not find significant differences in serum uric acid levels between the interferon beta 1a and interferon beta 1b groups (p=0.98). These results indicate that one of the beneficial effects of interferon beta in MS might be based on the elevation of serum uric acid levels as a natural scavenger of peroxynitrite." @default.
- W2547135739 created "2016-11-11" @default.
- W2547135739 creator A5003288604 @default.
- W2547135739 creator A5008352668 @default.
- W2547135739 creator A5040904016 @default.
- W2547135739 creator A5050259067 @default.
- W2547135739 date "2017-10-19" @default.
- W2547135739 modified "2023-10-17" @default.
- W2547135739 title "Higher Serum Uric Acid Levels in Multiple Sclerosis Patients After Longterm Interferon Beta Treatment" @default.
- W2547135739 cites W1965893696 @default.
- W2547135739 cites W1974771163 @default.
- W2547135739 cites W1977490008 @default.
- W2547135739 cites W2002921831 @default.
- W2547135739 cites W2024061399 @default.
- W2547135739 cites W2051214947 @default.
- W2547135739 cites W2076314035 @default.
- W2547135739 cites W2080090922 @default.
- W2547135739 cites W2087651392 @default.
- W2547135739 cites W2105490558 @default.
- W2547135739 cites W2110812724 @default.
- W2547135739 cites W2112165124 @default.
- W2547135739 cites W2117280294 @default.
- W2547135739 cites W2131500883 @default.
- W2547135739 cites W2138064547 @default.
- W2547135739 cites W2152375138 @default.
- W2547135739 cites W2315090522 @default.
- W2547135739 cites W2316517142 @default.
- W2547135739 cites W4302790144 @default.
- W2547135739 doi "https://doi.org/10.1515/sjecr-2016-0052" @default.
- W2547135739 hasPublicationYear "2017" @default.
- W2547135739 type Work @default.
- W2547135739 sameAs 2547135739 @default.
- W2547135739 citedByCount "2" @default.
- W2547135739 countsByYear W25471357392022 @default.
- W2547135739 countsByYear W25471357392023 @default.
- W2547135739 crossrefType "journal-article" @default.
- W2547135739 hasAuthorship W2547135739A5003288604 @default.
- W2547135739 hasAuthorship W2547135739A5008352668 @default.
- W2547135739 hasAuthorship W2547135739A5040904016 @default.
- W2547135739 hasAuthorship W2547135739A5050259067 @default.
- W2547135739 hasBestOaLocation W25471357391 @default.
- W2547135739 hasConcept C102652120 @default.
- W2547135739 hasConcept C126322002 @default.
- W2547135739 hasConcept C134018914 @default.
- W2547135739 hasConcept C203014093 @default.
- W2547135739 hasConcept C2776178377 @default.
- W2547135739 hasConcept C2779881121 @default.
- W2547135739 hasConcept C2780640218 @default.
- W2547135739 hasConcept C71924100 @default.
- W2547135739 hasConcept C90924648 @default.
- W2547135739 hasConceptScore W2547135739C102652120 @default.
- W2547135739 hasConceptScore W2547135739C126322002 @default.
- W2547135739 hasConceptScore W2547135739C134018914 @default.
- W2547135739 hasConceptScore W2547135739C203014093 @default.
- W2547135739 hasConceptScore W2547135739C2776178377 @default.
- W2547135739 hasConceptScore W2547135739C2779881121 @default.
- W2547135739 hasConceptScore W2547135739C2780640218 @default.
- W2547135739 hasConceptScore W2547135739C71924100 @default.
- W2547135739 hasConceptScore W2547135739C90924648 @default.
- W2547135739 hasIssue "3" @default.
- W2547135739 hasLocation W25471357391 @default.
- W2547135739 hasOpenAccess W2547135739 @default.
- W2547135739 hasPrimaryLocation W25471357391 @default.
- W2547135739 hasRelatedWork W1966504330 @default.
- W2547135739 hasRelatedWork W1966775726 @default.
- W2547135739 hasRelatedWork W1979139803 @default.
- W2547135739 hasRelatedWork W1991560548 @default.
- W2547135739 hasRelatedWork W2030889776 @default.
- W2547135739 hasRelatedWork W2037631372 @default.
- W2547135739 hasRelatedWork W2040058909 @default.
- W2547135739 hasRelatedWork W2132898409 @default.
- W2547135739 hasRelatedWork W2748952813 @default.
- W2547135739 hasRelatedWork W4249176446 @default.
- W2547135739 hasVolume "18" @default.
- W2547135739 isParatext "false" @default.
- W2547135739 isRetracted "false" @default.
- W2547135739 magId "2547135739" @default.
- W2547135739 workType "article" @default.